SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
600.00    -10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread: 2.00 (0.334%)
Market Cap: £726.05m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Oxford Biomedica News

LONDON MARKET CLOSE: Stocks up as G20 finance heads meet; Netflix down
20 Apr 2022

LONDON MARKET CLOSE: Stocks up as G20 finance heads meet; Netflix down

(Alliance News) - Stocks in London ended higher on Wednesday as investors continued to track the war in Ukraine, while in the US, Netflix weighed on t...

LONDON MARKET MIDDAY: Europe pushes higher as Netflix shockwave wanes
20 Apr 2022

LONDON MARKET MIDDAY: Europe pushes higher as Netflix shockwave wanes

(Alliance News) - The FTSE 100 index moved upwards with a bit more conviction as the morning progressed in London on Wednesday, shaking off a mixed US...

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause
20 Apr 2022

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause

(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for...

Oxford Biomedica reports year of solid growth
20 Apr 2022

Oxford Biomedica reports year of solid growth

(Sharecast News) - Oxford Biomedica reported a 63% improvement in total revenues in its preliminary results on Wednesday, to £142.8m, although it...

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree
1 Feb 2022

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies
1 Feb 2022

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies

Oxford Biomedica's Parkinson's licensee pulls out
1 Feb 2022

Oxford Biomedica's Parkinson's licensee pulls out

(Sharecast News) - Oxford Biomedica's licensee for a Parkinson's disease treatment has pulled out of development and returned the rights to the UK com...